COVID-19-Related News from Bar-Ilan University

COVID-19: 40% of new serious cases are under 60 – here’s why

There is a very disturbing increase in serious cases of COVID-19 among young people, according to a report released by the Coronavirus Knowledge and Information Center. “There is a clear decrease in serious illness among those ages 60 and older,” the report said. “There is an increase in the number of patients in serious condition among younger groups, which constituted about 40% of new serious cases.” Prof. Cyrille Cohen, head of the immunotherapy laboratory at Bar-Ilan University weighs in. Read More

One Pfizer dose boosts immunity in previous Covid patients

Healthcare workers previously infected with the SARS-CoV-2 coronavirus had a strong immune response to one dose of the Pfizer/BioNTech Covid19 vaccine, according to research from Israel’s Bar-Ilan University medical school and its affiliated Ziv Medical Center in Safed (Tzfat). Read More

COVID-19 Immunization Campaign

In February, Bar-Ilan University, in cooperation with Magen David Adom, opened a COVID-19 vaccination site at the University’s Kofkin Faculty of Engineering for members of all Israeli HMOs. Read More

COVID-19 and the Vaccine

Researchers from Bar-Ilan University and Ziv Medical Center now report preliminary evidence that people previously infected with the virus responded very strongly to one dose of the Pfizer vaccine, regardless of when they were infected and whether or not they had detectable antibodies against COVID-19 prior to receiving the vaccine. Read More

The Latest on COVID-19

World-renowned experts in virology, immunology, and epidemiology delivered a virtual briefing on the coronavirus pandemic and Israel’s ongoing vaccination campaign to an audience that included hundreds of health ministry representatives and members of the Jewish community from around the world. The event was hosted by the Center for Jewish Impact and Bar-Ilan University. Read More

Israeli and Diaspora Experts Meet to Exchange Views

Prof. Michael Edelstein who teaches Public Health and Epidemiology at Bar-Ilan University’s Azrieli Faculty of Medicine, said that while it is true that Israel is one of the countries where vaccinating the population is the fastest, “the pace is slowing as some challenges emerge. Some populations are getting vaccinated faster than others and it is urgent to understand why”. Read More

Israeli COVID Cure?

A group of Israeli researchers has launched a Phase II study of a drug that they believe could keep patients off mechanical ventilation and speed their recovery. The trial, which is being collectively run by Ziv and Rambam medical centers with researchers from Bar-Ilan University and Technion-Israel Institute of Technology, is examining the use of a drug based on a naturally occurring peptide called angiotensin 1-7 to help counter the impact of COVID-19 on the lungs. Read More

Web Searches Could Help Detect Covid-19 Outbreaks Early

A complex algorithm, maintained in part by Bar-Ilan University epidemiologist, uses popular Google searches to predict which English towns are headed for outbreaks — 17 days ahead. According to Bar-Ilan University’s Prof. Michael Edelstein, who co-authored the research, the best chance of tackling health emergencies such as the Covid-19 pandemic is to detect them early in order to act early.

“Using innovative approaches to disease detection such as analyzing internet search activity to complement established approaches is the best way to identify outbreaks early,” he said. Read More

Sonovia: Technology to Eliminate Bacteria and Viruses on Fabric

Israeli startup, Sonovia, has developed a technology to impregnate the fabric used in masks and other applications to protect the wearer from COVID-19 and other viruses. Sonovia was founded in 2013 following over 10 years of research by Bar-Ilan University and a four-year, EU-funded research project looking into fighting hospital-acquired infections. Its patented technology uses ultrasonic soundwaves to physically infuse zinc oxide nanoparticles onto the fabric. Read More

Moderna Chief Medical Officer to Receive Honorary Doctorate from BIU

This May, Dr. Tal Zaks, noted chief medical officer of Moderna, will be granted an honorary doctorate from Bar-Ilan University for his company’s development of a coronavirus vaccine. Read More

Can COVID-19 Impair Male Fertility?

Initially, the coronavirus was thought to be a type of flu that affects the respiratory system. Today, it is known that the virus affects many bodily systems, including the heart, the kidneys, and other organs, and that some of the damage is only manifested after recovery.

Research conducted by Prof. Johnny S. Younis, Vice-Dean for Clinical Education at Bar-Ilan University’s Azrieli Faculty of Medicine, contributes to our understanding of the possible long-term effects of COVID-19, specifically with regards to male fertility. Read More